T1	HMM 324 332	efficacy
T2	HMM 337 343	safety
T3	HMM 957 989	progression-free survival (PFS).
T4	HMM 1038 1048	Median PFS
T5	HMM 1171 1194	median overall survival
T6	HMM 1290 1313	objective response rate
T7	HMM 1357 1376	â‰¥3 adverse events
T8	HMM 1391 1411	included neutropenia
T9	HMM 1426 1438	and diarrhea
T10	HMM 1538 1557	toward improved PFS
T11	HMM 1577 1600	had acceptable toxicity
